Advances in the diagnosis and treatment of osteoporosis and sarcopenia

Haodong Jiang; Aoguo Zeng; Yanhui Wang; Cuizhong Liu

doi:10.23977/medsc.2024.050207

Advances in the diagnosis and treatment of osteoporosis and sarcopenia

Download as PDF

DOI: 10.23977/medsc.2024.050207 | Downloads: 4 | Views: 86

Author(s)

Haodong Jiang ¹, Aoguo Zeng ¹, Yanhui Wang ¹, Cuizhong Liu ²

Affiliation(s)

¹ The First Hospital Affiliated with Hunan Normal University, Changsha, Hunan, China
² Hunan Provincial People`s Hospital, Changsha, Hunan, China

Corresponding Author

Cuizhong Liu

ABSTRACT

With the increase in human life expectancy and the advent of an aging society, the prevalence of osteoporosis and sarcopenia, as age-accelerating diseases, has been increasing year by year, creating a heavy burden on society. Osteoporosis and sarcopenia have multiple etiologies, including genetic, metabolic, lifestyle, and exercise variables. Moreover, poor nutritional status, including insufficient consumption of calcium, vitamin D, and protein, as well as decreased physical activity, are major risk factors for sarcopenia and osteoporosis. Osteoporosis and sarcopenia raise chances of fractures and falls, affects exercise capacity, reduces quality of life, and directly or indirectly affects the life expectancy of the population. Adequate nutritional supplementation and physical activity are the main strategies for preventing and delaying osteoporosis and sarcopenia, in addition to pharmacological interventions that are thought to be potentially beneficial. This review provides the progress of epidemiologic, diagnostic, and therapeutic studies of osteoporosis and sarcopenia, and provides some reference value for further research.

KEYWORDS

Osteoporosis; sarcopenia; epidemiology; diagnosis; treatment

CITE THIS PAPER

Haodong Jiang, Aoguo Zeng, Yanhui Wang, Cuizhong Liu, Advances in the diagnosis and treatment of osteoporosis and sarcopenia. MEDS Clinical Medicine (2024) Vol. 5: 48-53. DOI: http://dx.doi.org/10.23977/medsc.2024.050207.

REFERENCES

[1] Ozpak A O, Atalay B. Post-menopausal osteoporosis: do body composition, nutritional habits, and physical activity affect bone mineral density?[J]. Nutr Hosp, 2020,37(5):977-983.
[2] Aibar-Almazan A, Voltes-Martinez A, Castellote-Caballero Y, et al. Current Status of the Diagnosis and Management of Osteoporosis[J]. Int J Mol Sci, 2022,23(16).
[3] Puth M T, Klaschik M, Schmid M, et al. Prevalence and comorbidity of osteoporosis- a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany[J]. BMC Musculoskelet Disord, 2018,19(1):144.
[4] Wright N C, Saag K G, Dawson-Hughes B, et al. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA[J]. Osteoporos Int, 2017,28(4):1225-1232.
[5] Osteoporosis and bone mineral salt disease branch, Chinese Medical Association.Epidemiological survey on osteoporosis in China and results of the "Healthy Bones" campaign[J]. Chinese Journal of Osteoporosis and Bone Mineral Salt Diseases. 2019,12(04):317-318.
[6] Goljanek-Whysall K, Iwanejko L A, Vasilaki A, et al. Ageing in relation to skeletal muscle dysfunction: redox homoeostasis to regulation of gene expression[J]. Mamm Genome, 2016,27(7-8):341-357.
[7] Liu Juan, Ding Qingqing, Zhou Baiyu, et al. Expert consensus on the diagnosis and treatment of sarcopenia in the elderly in China (2021)[J]. Chinese Journal of Geriatrics, 2021,40(8):943-952.
[8] Chen L K, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment[J]. J Am Med Dir Assoc, 2020,21(3):300-307.
[9] Cheng Qun, Zheng Lili, Zhang Zhenlin. Epidemiology and pathogenesis of sarcopenia[J]. Chinese Journal of Osteoporosis and Bone Mineral Salt Diseases, 2016,9(03):228-235.
[10] Wang Xuan, Hu Xinglv, Xu Lei, et al. Progress in the correlation between sarcopenia and osteoporosis[J]. Chinese Journal of Osteoporosis, 2023,29(10):1533-1537.
[11] Sun Chao, Hou Liming, Jian Weiming, et al. Survey on the prevalence of sarcopenia and related factors in the elderly population over 60 years old in China[J]. Chinese Journal of Geriatrics, 2021,40(8):981-986.
[12] Chin K Y. A review on the performance of osteoporosis self-assessment tool for Asians in determining osteoporosis and fracture risk[J]. Postgrad Med, 2017,129(7):734-746.
[13] Kharroubi A, Saba E, Ghannam I, et al. Evaluation of the validity of osteoporosis and fracture risk assessment tools (IOF One Minute Test, SCORE, and FRAX) in postmenopausal Palestinian women[J]. Arch Osteoporos, 2017,12(1):6.
[14] Kendler D L, Compston J, Carey J J, et al. Repeating Measurement of Bone Mineral Density when Monitoring with Dual-energy X-ray Absorptiometry: 2019 ISCD Official Position[J]. J Clin Densitom, 2019,22(4):489-500.
[15] Xue S, Zhang Y, Qiao W, et al. An Updated Reference for Calculating Bone Mineral Density T-Scores[J]. J Clin Endocrinol Metab, 2021,106(7):e2613-e2621.
[16] Xu X M, Li N, Li K, et al. Discordance in diagnosis of osteoporosis by quantitative computed tomography and dual-energy X-ray absorptiometry in Chinese elderly men[J]. J Orthop Translat, 2019,18:59-64.
[17] Filippiadis D K, Charalampopoulos G, Mazioti A, et al. Bone and Soft-Tissue Biopsies: What You Need to Know[J]. Semin Intervent Radiol, 2018,35(4):215-220.
[18] Greenblatt M B, Tsai J N, Wein M N. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease[J]. Clin Chem, 2017,63(2):464-474.
[19] Pisani P, Renna M D, Conversano F, et al. Screening and early diagnosis of osteoporosis through X-ray and ultrasound based techniques[J]. World J Radiol, 2013,5(11):398-410.
[20] Wheater G, Elshahaly M, Tuck S P, et al. The clinical utility of bone marker measurements in osteoporosis[J]. J Transl Med, 2013,11:201.
[21] Sharma U, Pal D, Prasad R. Alkaline phosphatase: an overview[J]. Indian J Clin Biochem, 2014,29(3):269-278.
[22] Greenblatt M B, Tsai J N, Wein M N. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease[J]. Clin Chem, 2017,63(2):464-474.
[23] Chen L K, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment[J]. J Am Med Dir Assoc, 2020,21(3):300-307.
[24] Krzyminska-Siemaszko R, Deskur-Smielecka E, Styszynski A, et al. Polish Translation and Validation of the Mini Sarcopenia Risk Assessment (MSRA) Questionnaire to Assess Nutritional and Non-Nutritional Risk Factors of Sarcopenia in Older Adults[J]. Nutrients, 2021,13(4).
[25] Ishii S, Tanaka T, Shibasaki K, et al. Development of a simple screening test for sarcopenia in older adults[J]. Geriatr Gerontol Int, 2014,14 Suppl 1:93-101.
[26] Li Min, Song Guiqi, Ren Haiyan, et al. Application of Ishii score in screening for sarcopenia in community-dwelling older adults[J]. China Nursing Management, 2018,18(08):1034-1038.
[27] Huang Hong-Xing, Shi Xiao-Lin, Li Sheng-Hua, et al. Expert consensus on sarcopenia-osteoporosis[J]. Chinese Journal of Osteoporosis, 2022,28(11):1561-1570.
[28] Yan Chengxi, Tang Guangcai, Cheng Xiaoguang. Current status and research progress of quantitative measurement of sarcopenia [J]. Chinese Journal of Osteoporosis, 2018,24(06):814-819.
[29] Verdu-Diaz J, Alonso-Perez J, Nunez-Peralta C, et al. Accuracy of a machine learning muscle MRI-based tool for the diagnosis of muscular dystrophies[J]. Neurology, 2020,94(10):e1094-e1102.
[30] Diaz-Manera J, Llauger J, Gallardo E, et al. Muscle MRI in muscular dystrophies [J]. Acta Myol, 2015, 34(2-3):95-108.
[31] Cawthon P M, Orwoll E S, Peters K E, et al. Strong Relation Between Muscle Mass Determined by D3-creatine Dilution, Physical Performance, and Incidence of Falls and Mobility Limitations in a Prospective Cohort of Older Men[J]. J Gerontol A Biol Sci Med Sci, 2019,74(6):844-852.
[32] Park C, Sharafkhaneh A, Bryant M S, et al. Toward Remote Assessment of Physical Frailty Using Sensor-based Sit-to-stand Test [J]. J Surg Res, 2021,263:130-139.
[33] Jarvis L M, Peterson M J, Caves K M. Development, Validity, and Reliability of a Novel Walking Speed Measurement Device: the GaitBox [J]. Gait Posture, 2021,84:52-57.
[34] Daly R M, Gianoudis J, Kersh M E, et al. Effects of a 12-Month Supervised, Community-Based, Multimodal Exercise Program Followed by a 6-Month Research-to-Practice Transition on Bone Mineral Density, Trabecular Microarchitecture, and Physical Function in Older Adults: A Randomized Controlled Trial[J]. J Bone Miner Res, 2020, 35(3): 419-429.
[35] Kirk B, Mooney K, Amirabdollahian F, et al. Exercise and Dietary-Protein as a Countermeasure to Skeletal Muscle Weakness: Liverpool Hope University - Sarcopenia Aging Trial (LHU-SAT)[J]. Front Physiol, 2019,10:445.
[36] Sherrington C, Fairhall N J, Wallbank G K, et al. Exercise for preventing falls in older people living in the community[J]. Cochrane Database Syst Rev, 2019,1(1):CD12424.
[37] Wilkinson D J, Hossain T, Hill D S, et al. Effects of leucine and its metabolite beta-hydroxy-beta-methylbutyrate on human skeletal muscle protein metabolism[J]. J Physiol, 2013,591(11):2911-2923.
[38] Verlaan S, Maier A B, Bauer J M, et al. Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults - The PROVIDE study[J]. Clin Nutr, 2018,37(2):551-557.
[39] Candow D G, Forbes S C, Chilibeck P D, et al. Effectiveness of Creatine Supplementation on Aging Muscle and Bone: Focus on Falls Prevention and Inflammation[J]. J Clin Med, 2019,8(4).
[40] Kirk B, Miller S, Zanker J, et al. A clinical guide to the pathophysiology, diagnosis and treatment of osteosarcopenia [J]. Maturitas, 2020, 140:27-33.

Subscription

E-Mail Alert

Downloads:	4558
Visits:	197287

Advances in the diagnosis and treatment of osteoporosis and sarcopenia

Author(s)

Affiliation(s)

Corresponding Author

ABSTRACT

KEYWORDS

CITE THIS PAPER

REFERENCES

RESOURCES

JOIN US

PUBLICATION SERVICES

CONTACT US